• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

January 1, 2012
Glen Spielmans, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Glen Spielmans, PhD Associate professor of psychology, Metropolitan State University, St. Paul, MN Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Subject:
GENETICS

Short Description:
Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

Background:

Common sense dictates that genetic predispositions probably interact with life stressors to influence our mental health. Plenty of research has been published to evaluate whether this is actually true, but findings have been mixed. The first widely reported positive study, for instance, found that patients who had short alleles (versions) of the serotonin transporter gene (5-HTTLPR) were more likely to suffer depression in response to stressful life events than patients with normal alleles (Caspi A et al, Science 2003;301:386–389).

In response to this intriguing finding, a slew of studies tried to replicate this result. One meta-analysis of 14 direct replication studies found no significant link between 5-HTTLPR variation and depressive response to stressors (Risch N et al, JAMA 2009;301:2462–2471). But a later meta-analysis cast a wider net, including several indirect replications which used somewhat different measures of stress (such as hip fractures and heart disease) and depression—and it found a strong association between 5-HTTLPR variation, stress and depression (Karg K et al, Arch Gen Psychiatry 2011;68:444–454).

The latest study throws a monkey wrench into not only how 5-HTTLPR combines with stress but into all gene/ environment findings in psychiatry. Researchers examined results from all 103 published studies of gene/environment interactions in psychiatry published from 2000 to 2009. They found that while a whopping 96% of original gene/environment interaction studies were positive, only 27% of replication attempts were successful.

Replication studies with larger sample sizes were unlikely to find significant results, while positive replications usually had smaller sample sizes—implying that the most reliable replications are the most likely to cast the original findings into doubt (Duncan LE et al, Am J Psychiatry 2011;168:1041–1049).

TCPR's Take:
Dependable findings of gene/environment associations could eventually be helpful in both diagnosis and treatment—but we must await consistent positive replications before jumping on board.
General Psychiatry
KEYWORDS depressive_disorder genetics_and_psychiatry
    Ccpr octnovdec2020 qa1 headshot spielmans 150x150
    Glen Spielmans, PhD

    L-Methylfolate May Offer Modest Boost to Antidepressants

    More from this author
    www.thecarlatreport.com
    Issue Date: January 1, 2012
    SUBSCRIBE NOW
    Table Of Contents
    Deplin: Is it Just Folate by Another Name?
    Nuedexta for Pseudobulbar Affect
    Complementary and Alternative Medicine for Mood Disorders
    Genes Plus Environment in Psychiatry: View Positive Studies Skeptically
    Can Instant Messaging Enhance Treatment Outcomes?
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.